Vision Loss
Community Advocate

Better to see something once than hear about it a thousand times!

Empowering the Visually Impaired

Meet Miss Ruth, a passionate community advocate for those with vision loss. Through her articles, podcasts, videos, and resource sharing, she strives to empower and support the visually impaired community.

Tinlarebant NDA Submission Completed for Stargardt Disease Type 1, Targeting First Approved Therapy

Author(s)Ophthalmology Times Staff June 17, 2026 Fact checked by: Lucia Gambuzza Key Takeaways Belite’s rolling NDA for tinlarebant advances under Breakthrough Therapy Designation, with Fast Track,

Tinlarebant NDA Submission Completed for Stargardt Disease Type 1, Targeting First Approved Therapy Read More »

Accessibility Toolbar